The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)
NCT05951751 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2800
Last updated 2024-06-20
Summary
The TRI-MOM program aims to implement and evaluate a simplified (based on inexpensive rapid diagnostic tests), integrated (in governmental health facilities) and coordinated (between health care workers) strategy for the triple elimination of HIV, syphilis and HBV mother-to-child transmission (MTCT) in nine maternal and child health services, 5 in Burkina Faso and 5 in The Gambia.
The TRI-MOM program has two components:
1. an "intervention" component consisting of a pilot study to reinforce the antenatal screening and prevention of MTCT (PMTCT) capacities for the 3 targeted infections through the implementation of a simplified, integrated and coordinated strategy of triple elimination of MTCT.
2. an "evaluation" component which will assess the impact of the TRI-MOM strategy on PMTCT services, reduction of HBV MTCT and women empowerment.
Conditions
- Hiv
- Syphilis
- HBV
Interventions
- OTHER
-
TRI-MOM intervention
The TRI-MOM strategy includes 4 main activities: 1. Training of healthcare professionals in charge of maternal health (nurses, midwives and doctors in charge of maternal health services) 2. Triple screening of HIV, Syphilis and HBV by rapid diagnostic tests 3. Assessment and treatment of women positive for any of the 3 targeted infections 4. Raising awareness on MTCT among pregnant women visiting antenatal services and empowering women infected with at least one of the three infections
Sponsors & Collaborators
-
Centre Muraz
collaborator OTHER - collaborator OTHER_GOV
-
Institut Pasteur
collaborator INDUSTRY -
REVS PLUS Burkina Faso
collaborator UNKNOWN -
Young Gambian Mums Fund
collaborator UNKNOWN -
National AIDS Control Program Gambia
collaborator UNKNOWN -
Institut de Recherche pour le Developpement
lead OTHER_GOV
Principal Investigators
-
Sylvie Boyer, PhD · UMR 1252 SESSTIM
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-03-18
- Primary Completion
- 2025-05-31
- Completion
- 2025-05-31
Countries
- Burkina Faso
- The Gambia
Study Locations
More Related Trials
-
Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety
NCT03519503 ·Status: COMPLETED
-
Safe Generations Plus: Swaziland PMTCT LTF Study
NCT02969161 ·Status: COMPLETED
-
Dual bNAb Treatment in Children
NCT03707977 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Home-based Partner Education and Testing (HOPE) Study
NCT01784783 ·Status: COMPLETED ·Phase: NA
-
National Cohort of Children Born to HIV-positive Mothers
NCT03306251 ·Status: UNKNOWN
-
Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
NCT00753324 ·Status: COMPLETED ·Phase: PHASE4
-
Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial
NCT00936195 ·Status: WITHDRAWN ·Phase: PHASE3
-
Microbicide/PrEP Acceptability Among Mothers and Male Partners in Africa
NCT03648931 ·Status: COMPLETED
-
Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
NCT00334256 ·Status: COMPLETED ·Phase: PHASE2
-
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145 ·Status: COMPLETED
-
Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
NCT00270296 ·Status: COMPLETED ·Phase: PHASE2
-
Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women
NCT03227731 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
NCT06267508 ·Status: RECRUITING
-
Introduction Study of Dual HIV & Syphilis Rapid Diagnostic Tests in Antenatal Clinics in Colombia
NCT02454816 ·Status: COMPLETED ·Phase: NA
-
Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services
NCT02479659 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed Newborns
NCT05017558 ·Status: UNKNOWN
-
STI Testing to Enhance PrEP Use in Pregnancy
NCT06919614 ·Status: RECRUITING ·Phase: PHASE3
-
Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV
NCT03869944 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1
NCT06517693 ·Status: RECRUITING ·Phase: PHASE1
-
Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project
NCT02043418 ·Status: ACTIVE_NOT_RECRUITING
-
Swaziland Safe Generations
NCT01891799 ·Status: COMPLETED
-
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
NCT06158126 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of the Population-level Impact of PMTCT Option B+ in Zimbabwe
NCT03388398 ·Status: COMPLETED
-
A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth
NCT00001007 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers
NCT00982579 ·Status: COMPLETED ·Phase: PHASE1